Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)

by | Aug 27, 2025 | Clinical Trials | 0 comments

​ Conditions: Intraprostatic Prostate Cancer

Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT); Drug: Androgen Deprivation Therapy (ADT)

Sponsors: NYU Langone Health

Recruiting Conditions: Intraprostatic Prostate Cancer
Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT); Drug: Androgen Deprivation Therapy (ADT)
Sponsors: NYU Langone Health
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *